Pfizer-BioNTech seek FDA authorization for 2nd COVID booster for older adults
Pfizer says it will soon submit data on a fourth COVID shot to the Food and Drug Administration. What is the case for another booster, and is there a downside to the approach?
[Copyright 2022 NPR]
